Role of Estrogen and Its Receptors in Adipose Tissue Glucose Metabolism in Pre- and Postmenopausal Women

• Published in: The journal of clinical endocrinology and metabolism Vol. 107; no. 5; pp. e1879 - e1889
• Main Authors: Ahmed, Fozia, Kamble, Prasad G, Hetty, Susanne, Fanni, Giovanni, Vranic, Milica, Sarsenbayeva, Assel, Kristófi, Robin, Almby, Kristina, Svensson, Maria K, Pereira, Maria J, Eriksson, Jan W
• Format: Journal Article
• Language: English
• Published: United States Oxford University Press 19.04.2022
• Subjects: adipose tissue; Adipose Tissue - metabolism; Adipose tissues; Biotechnology industry; Cholesterol - metabolism; Dextrose; Diabetes Mellitus, Type 2 - metabolism; Estradiol; Estrogen Receptor alpha - genetics; Estrogen Receptor alpha - metabolism; Estrogens - metabolism; Female; Gene expression; Genes; Glucose; Glucose - metabolism; Humans; Insulin; Insulin resistance; Menopause; Online Only; Phenols; Polymorphism, Single Nucleotide; Postmenopausal women; Postmenopause; Receptors, Estrogen - genetics; Receptors, Estrogen - metabolism; Scientific equipment and supplies industry; Single nucleotide polymorphisms; Triglycerides; Type 2 diabetes; United States; Sweden; adipose tissue; type 2 diabetes; menopause; insulin resistance; estradiol
• ISSN: 0021-972X; 1945-7197; 1945-7197
• DOI: 10.1210/clinem/dgac042

Reduced estrogen levels in postmenopausal women predispose them to metabolic side effects, including insulin resistance and type 2 diabetes; however, the cellular mechanisms are not well understood. This work aimed to study the expression of estrogen receptors in adipose tissue from pre- and postmenopausal women and the effects of estradiol (E2) on glucose uptake of adipocytes. Subcutaneous (SAT) and visceral adipose tissue (VAT) obtained from pre- and postmenopausal women (19-51 and 46-75 years old, respectively) were used to measure gene expression of ESR1 and ESR2. SAT tissue was incubated with E2, and glucose uptake and estrogen receptor levels were measured. Polymorphisms in ESR1 and ESR2 were addressed in public databases to identify single nucleotide polymorphisms associated with metabolic traits. ESR2 expression was lower in pre- vs postmenopausal women, corresponding to lower ESR1:ESR2 gene expression ratio in postmenopausal women. In premenopausal women, the expression of ESR1 was higher in VAT than in SAT. In both pre- and postmenopausal women, ESR2 expression was lower in VAT than in SAT. In late, but not pre- or early postmenopausal women, E2 reduced glucose uptake and GLUT4 protein and increased expression of ESR2. ESR1 polymorphisms were associated with weight, body fat distribution, and total cholesterol, and ESR2 polymorphisms were associated with total cholesterol and triglyceride levels and with body fat percentage. E2 inhibits glucose utilization in human adipocytes in late postmenopausal women. Changes in glucose utilization over time since menopause may be explained by a lower ESR1:ESR2 ratio. This can have clinical implications on the timing of estrogen treatment in postmenopausal women.